Nu-Med Plus (NUMD) Total Debt Growth (1y) (2012 - 2021)
Nu-Med Plus (NUMD) Total Debt Growth (1y) (2012 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -5.76% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn | 19.06% |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -92.06% |
| Dec 31, 2020 | -91.79% |
| Sep 30, 2020 | 4,170.48% |
| Jun 30, 2020 | 2,016.51% |
| Mar 31, 2020 | 1,304.92% |
| Dec 31, 2019 | 421.17% |
| Sep 30, 2019 | -78.00% |
| Jun 30, 2019 | -63.35% |
| Mar 31, 2019 | -52.92% |
| Dec 31, 2018 | 9.78% |
| Sep 30, 2018 | -39.07% |
| Jun 30, 2018 | -34.24% |
| Dec 31, 2012 | 2,164.71% |